SEC Form 4 · accession 0001886986-26-000004
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Blake Aftab
Officer — Chief Scientific Officer
Period of report
Jun 19, 2026
Accepted (ET)
Jun 23, 2026 · 6:49 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001720580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.10 | Jun 19, 2026 | A | 55,000 | A | — | Jun 18, 2036 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F11/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date with partial acceleration tied to certain performance milestones, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.